Login / Signup

Primary slow-coagulation transscleral cyclophotocoagulation laser treatment for medically recalcitrant neovascular glaucoma.

Mohamed M KhodeiryAlison J LauterMohamed S SayedYing HanRichard K Lee
Published in: The British journal of ophthalmology (2021)
Slow-coagulation TSCPC is an effective and relatively safe initial surgical intervention in medically uncontrolled NVG.
Keyphrases
  • randomized controlled trial
  • vascular endothelial growth factor
  • high speed
  • combination therapy
  • replacement therapy
  • endothelial cells